malaria

by Kwesi Akonu Adom Mensah Forson, The Conversation edited by Gaby Clark, reviewed by Andrew Zinin  Editors’ notes  The GIST Add as preferred source Credit: Jimmy Chan from Pexels Every year, malaria kills more than 600,000 people worldwide. Most of them are children under 5 in sub-Saharan Africa. But the disease isn’t confined to poor, rural areas—it’s a global threat

by QIMR Berghofer Medical Research Institute edited by Lisa Lock, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain A new clinical trial led by QIMR Berghofer, in collaboration with University of Sunshine Coast Clinical Trials Network has found a medication currently used for some blood disorders could help the body

by Barcelona Institute for Global Health edited by Sadie Harley, reviewed by Andrew Zinin Ivermectin tablets used for the BOHEMIA trial in Kenya. Credit: Life Spark Studios/BOHEMIA project Ivermectin administered to the whole population significantly reduces malaria transmission, offering new hope in the fight against the disease. The BOHEMIA trial, the largest study on ivermectin for malaria to

by Karolinska Institutet edited by Sadie Harley, reviewed by Andrew Zinin   Credit: CC0 Public Domain Researchers at Karolinska Institutet have identified over 250 proteins that are strongly affected by malaria, which could help predict the severity of the disease and thus enable faster treatment for the most critical patients. The study, published in the journal Immunity, was conducted on 72

by Delthia Ricks, Phys.org edited by Sadie Harley, reviewed by Robert Egan   Credit: Pixabay/CC0 Public Domain Monoclonal antibodies provide protection against a wide range of infectious microbes, and now, in a series of elegant laboratory experiments, scientists have uncovered how a pair of these lab-engineered molecules fight malaria. The newly developed antibodies have arrived at a critical

Malaria parasites can hide in people’s bodies for years or even decades without causing symptoms by shutting down the genes that make them visible to the immune system, a new report found. This discovery explains how people can remain infected years after developing malaria and spread the disease through mosquitos that bite them, said Kirk